Sponsor Pipeline

Mediar Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
3
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07287670
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic…		 Trial sites expanded: 6 -> 58 locations
Active Trials by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07287670 EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic… Diffuse Cutaneous Systemic Sclerosis Recruiting
NCT06967805 WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis Recruiting
Phase 1
NCT07473323 Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease Healthy Adult Participants Recruiting
Disease Areas
Idiopathic Pulmonary Fibrosis (1) Scleroderma (1) Chronic Kidney Disease (1)
Get alerts when Mediar Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free